Thrombo-inflammation is a dangerous condition where blood clotting and inflammation occur simultaneously, overwhelming the ...
Venous thrombo-embolism also termed VTE is a significant healthcare issue in patients who undergo abdomino-pelvic surgery. It only gets worse, if the patient has been suffering from abdomino-pelvic ...
The integration of cisplatin-based chemotherapy and surgery in the first-line treatment of germ-cell tumours (GCT) has resulted in cure rates of approximately 80% in disseminated cases and more than ...
HELSINKI, 3 rd February 2025. Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan ...
With the backing of €2 million (US$2.17 million) in seed funding from venture capital company Adbio partners, French biotech Calida Therapeutics hopes that drawing on some U.S. academic research into ...
GENinCode Plc (AIM: GENI), Oxford, UK, the cardiovascular disease company focused on predictive genetics for the prevention of cardiovascular disease, announces the publication of its Thrombo inCode® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results